Summary
The immune response of diabetic patients to influenza vaccination was examined in 31 patients, 10 with Type 1 (insulin-dependent) diabetes and 21 with Type 2 (non-insulin-dependent diabetes), and in 19 normal subjects. Each received a single intramuscular injection of the 3 virus strains (A/Chile,A/Philippines,B/USSR) anti-influenza vaccine recommended by WHO. The antibody titre and the cell-mediated immune response to the 3 virus strains, as evaluated by the generation of activated lymphocytes and enumeration of B lymphocytes, were studied before and 18 h, 72 h and 1, 2, 3 and 6 weeks after vaccination. Overall, the humoral and cell-mediated immune responses were normal in both groups of patients. However, patients with Type 1 diabetes showed a statistically significant increase (p< 0.01) of antibody titre of the A/Chile and an increased percentage of B lymphocytes one week after vaccination compared to age-matched control subjects. Four out of 21 patients with Type 2 diabetes had no antibody response to all 3 virus strains. A significant reduction (p< 0.01) of the percentage of activated cells possessing receptors for interleukin-2 was observed 72 h after vaccination in patients with Type 2 diabetes compared to age-matched control subjects. None of the patients who received the vaccine developed influenza in the course of the following year. These results suggest that valid protection against the influenza virus can be obtained in patients with Type 1 and Type 2 diabetes.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Tyrrell DAJ, Smith JWG (1979) Vaccination against influenza A. Br Med Bull 35: 77–85
Clark A, Potter CW, Jennings R, Nicholl JP, Langrick, Schild GC, Wood JM, Tyrrell DAJ (1983) A comparison of live and inactivated influenza A virus vaccines. 2. Long term immunity. J Hygiene 90:361–370
Powers, RD, Hayden FG, Samuelson J, Gwaltney JM (1984) Immune response of adults to sequential influenza vaccination. J Med Virol 14:169–175
National Advisory Committee on Immunization (1984) Influenza vaccination for the 1984–1985. Can Med Assoc J 131: 304–305
Barg M, Roth M, Ducey C, Arquilla ER (1980) Immunologic functions in diabetes. In: Irvine WJ (ed) Immunology of diabetes. Teviot Edinburgh, pp 299–307
Horita M, Suzuki H, Onodera T, Ginsberg-Fellner F, Fauci AS, Notkins AL (1982) Abnormalities of immunoregulatory T-cell subsets in patients with insulin dependent diabetes mellitus. J Immunol 129: 1426–1429
Mahmoud AAF, Rodman HM, Mandel MA, Warren KS (1976) Induced and spontaneous diabetes mellitus and suppression of cell mediated immunologic responses: granuloma formation, delayed dermal reactivity, allograft rejection. J Clin Invest 57: 326–367
Bagdade JD, Nielson KL, Bulger RJ (1972) Reversible abnormalities in phagocytic function in poorly controlled diabetic patients. Am J Med Sci 263: 451–456
Iavicoli M, Di Mario U, Pozzilli P, Canalese J, Ventriglia L, Galfo C, Andreani D (1982) Impaired phagocytic function and increased immune complexes in diabetics with severe retinopathy. Diabetes 31: 7–11
McCuish AC, Jordan J, Campbell CJ, Duncan UP, Irvine WJ (1974) Phytohaemagglutinin lymphocyte transformation and circulating lymphocyte subpopulations in insulin dependent diabetes. Diabetes 23: 708–712
Pozzilli P, Zuccarini O, Iavicoli M, Andreani D, Sensi M, Spencer KM, Bottazzo GF, Beverley PCL, Kyner JL, Cudworth AG (1983) Monoclonal antibodies define abnormalities of T lymphocyte subsets in diabetes. Diabetes 32: 91–94
Arquilla ER, Stenger D (1984) In: Immunology in diabetes, Andreani D, Di Mario U, Federlin KF, Heding LG (eds), Kingston Medical Edinburgh, pp 265–275
Oxford JS, Yetts R, Schild GC (1982) Quantitation and analysis of the specificity of post-immunization antibodies to influenza B viruses using single radial haemolysis. J Hyg 88: 325–333
Haynes BF, Hemler ME, Mann DL, Eisenbarth GS, Shelhamer JH, Mostowski HS, Thomas CA, Strominger JL, Fauci AS (1980) Characterization of a monoclonal antibody (4F2) which binds to human monocytes and to a subset of activated lymphocytes. J Immunol 126:1409–1411
Leonard JJM, Depper T, Uchiyama T, Smith KA, Waldmann TA (1982) A monoclonal antibody that appears to recognize the receptor for human T cell growth factor: partial characterization of the receptor. Nature 300: 267–269
Hansen JA, Martin PJ, Nowinski RC (1980) Monoclonal antibodies identyfing a novel T cell antigen and la antigens of human lymphocytes. Immunogenetics 10: 247–260
Sensi M, Pozzilli P, Di Mario U (1984) A method to facilitate the reading of up to 60 samples of monoclonal antibody-fluorescence stained cells using Medicell HLA-DR plates. J Clin Lab Immunol 13:101–102
Delespesse G, Duchateau J, Bastenie PA, Lavaux JP, Collett H, Govaerts A (1974) Cell mediated immunity in diabetes mellitus. Clin Exp Immunol 18:461–466
Bottazzo GF, Pozzilli P, Mirakian R, Dean BM, Doniach D (1984) Early immunological events in diabetes. In: Immunology in diabetes. Andreani D, Di Mario U, Federlin KF, Heding LG (eds) Kimpton Medical, Edinburgh, pp 95–105
Banatvala JE, Bryant J, Schernthaner G, Borkenstein M, Schober E, Brown D, De Silva LM, Menser MA, Silink M (1985) Coxsackie B, mumps, rubella and cytomegalovirus specific IgM responses in patients with juvenile onset insulin dependent diabetes mellitus in Britain, Austria and Australia. Lancet 1: 1409–1412
Pozzilli P, Tam A, Gale EAM (1985) HLA-DR3 and activated lymphocytes: significance in autoimmunity. Lancet 2: 954–955 (Letter)
McMichael AJ, Gotch FM, Noble GR, Beare PAS (1983) Cytotoxic T-cell immunity to influenza. N Engl J Med 309: 13–17
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pozzilli, P., Gale, E.A.M., Visallil, N. et al. The immune response to influenza vaccination in diabetic patients. Diabetologia 29, 850–854 (1986). https://doi.org/10.1007/BF00870139
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00870139